
SVT (Supraventricular Tachycardia) Ablation is a highly effective, minimally invasive procedure used to permanently cure episodes of abnormally fast heart rhythms originating above the heart's lower chambers. It is the preferred treatment over lifelong medication for most patients due to its curative nature. By neutralizing the electrical "short circuits" in the heart, this procedure restores a normal, stable rhythm.
Recurrent episodes of abnormally fast heart rates (palpitations) that cause distress or anxiety.
SVT symptoms like dizziness, shortness of breath, or chest discomfort during episodes.
Ineffectiveness of anti-arrhythmic medications or a desire to stop daily heart drugs.
High-risk electrical pathways (like WPW) that could lead to more dangerous heart rhythms.
Frequent ER visits or hospitalizations due to the inability to stop a racing heart on your own.
AVNRT (AV Nodal Re-entrant Tachycardia): The most common type, caused by an extra pathway within the heart's main power station (the AV node).
AVRT (including WPW Syndrome): Caused by an extra muscle bridge (Accessory Pathway) connecting the upper and lower chambers.
Atrial Tachycardia: A specific tiny spot in the upper chamber that "fires" too rapidly and takes over the heart's rhythm.
Atrial Flutter: A circuit typically in the right atrium that creates a "sawtooth" rhythm on an ECG.
Mapping (The EP Study): 3 to 5 thin, flexible catheters are inserted through the femoral vein in the groin and guided to the heart under X-ray.
Triggering: The doctor "paces" the heart to deliberately trigger the SVT, allowing them to pinpoint the exact location of the electrical "leak."
Ablation: Once found, an ablation catheter delivers Radiofrequency (RF) heat or Cryoenergy (cold) to a tiny area (2–4 mm).
Verification: The clinical team waits about 20–30 minutes and attempts to re-trigger the SVT using medication or rapid pacing.
Completion: If the rhythm remains normal and the pathway is neutralized, the catheters are removed and the procedure is finalized.
Fasting for 8–12 hours is usually required; the procedure typically uses local anesthesia and deep sedation.
Blood tests to evaluate kidney function and blood clotting status (PT/INR).
Stopping anti-arrhythmic medications (like Beta-blockers) for 3–5 days prior to the test so the SVT can be induced.
Discussing any allergies to contrast dye, iodine, or local anesthetics.
Arranging for an overnight stay, though many 2026 cases are now "same-day" discharge.
Electrocardiogram (ECG): To record the baseline heart rhythm and identify the specific type of SVT.
Holter Monitor or Event Recorder: To capture infrequent episodes of fast heart rates during daily activities.
Echocardiogram: To ensure the heart's structure and pumping function are normal before the intervention.
Cardiac Stress Test: To observe how the heart rhythm behaves during physical exertion.
Electrophysiology (EP) Study: Performed as the first step of the ablation procedure to map the arrhythmia.
Post-Op Rest: You must lie flat for 4–6 hours immediately after the procedure to ensure the groin punctures seal properly.
Fast Recovery: Most patients return to work and light activity within 3 to 5 days.
Medication Cessation: Most patients can stop taking anti-arrhythmic drugs immediately after a successful procedure.
Short-term Restrictions: Avoid heavy lifting or intense gym workouts for at least one week.
Permanent Relief: For the vast majority, symptoms do not return, leading to a significant improvement in quality of life.
Provides a permanent cure rather than just managing symptoms with daily medication.
Extremely safe cardiac procedure with a major complication rate of less than 1%.
Eliminates the risk of fainting or accidents caused by sudden, rapid heartbeats.
Highly successful even in elderly patients or children with symptomatic SVT.
Modern 3D mapping reduces radiation (X-ray) exposure compared to older techniques.